Month: September 2020

Taaleri Plc – Managers’ Transactions – Robin Lindahl

Written by Customer Service on September 16, 2020. Posted in Public Companies.

TAALERI PLC MANAGERS’ TRANSACTIONS 16 SEPTEMBER 2020 AT 13.00 (EET)Person subject to the notification requirementName: Lindahl, RobinPosition: Chief Executive OfficerIssuer: Taaleri OyjLEI: 743700LSJBDD7TMLAD92Notification type: INITIAL NOTIFICATIONReference number: 743700LSJBDD7TMLAD92_20200916091850_2____________________________________________Transaction date: 2020-09-15Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000062195Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 3,025 Unit price: 7 EURAggregated transactions(1): Volume: 3,025 Volume weighted average price: 7 EURTaaleri PlcCommunicationsSophie Jolly, Head of Communications and IR, tel. +358 40 828 7317, sophie.jolly@taaleri.com

Vita Mobile Systems Announces Investment Agreement With Tangiers Global

Written by Customer Service on September 16, 2020. Posted in Public Companies.

IRVINE, CA, Sept. 16, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Vita Mobile Systems, Inc. (OTC PINK: VMSI), a technology company specializing in big data via digital imaging on mobile devices, today announced an investment agreement with Tangiers Global, LLC. Tangiers is a San Diego-based financial firm that provides working and expansion funding to small and microcap public companies and has been a VMSI partner since 2018.In anticipation of the Company’s audit completion, Tangiers and VMSI have executed an agreement for additional funding to ensure enough resources for all audit fees and filing expenses as VMSI looks to move forward post-audit.“We are thankful for all the trust and support that Tangiers has shown our organization over the past two years. We are excited about our company future, as well as the previously...

Rubicon Organics Signs Licensing Agreement with Wildflower for Topical Cannabis Products

Written by Customer Service on September 16, 2020. Posted in Public Companies.

First agreement for Rubicon Organics to enter 2.0 marketLeverages Rubicon Organics’ production, distribution and sales infrastructureSales expected to commence in the first half of 2021VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (“Rubicon Organics” or the “Company”) (CSE:ROMJ | OTCQX:ROMJF), is pleased to announce that it has entered into a brand licensing agreement (the “Agreement”) with Wildflower Brands Inc. (“Wildflower”) (CSE:SUN).Under the Agreement, Wildflower will license its brand and intellectual property to Rubicon Organics for the production of Wildflower-branded CBD Relief Sticks and CBD Cool Sticks in Canada (collectively “Wildflower Products”). Rubicon Organics will manufacture and distribute the Wildflower Products in Canada with product launch expected to be in the first...

Taaleri Oyj – Johdon liiketoimet – Juhani Elomaa

Written by Customer Service on September 16, 2020. Posted in Public Companies.

TAALERI OYJ:N JOHDON LIIKETOIMET 16.9.2020 KLO 13.00IlmoitusvelvollinenNimi: Elomaa, JuhaniAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Taaleri OyjLEI: 743700LSJBDD7TMLAD92Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700LSJBDD7TMLAD92_20200916092608_3____________________________________________Liiketoimen päivämäärä: 2020-09-15Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI4000062195Liiketoimen luonne: HANKINTALiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 725 Yksikköhinta: 7 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 725 Keskihinta: 7 EURTaaleri Oyj ViestintäSophie Jolly, Viestintä- ja sijoittajasuhdejohtaja, puh. 040 828 7317, sophie.jolly@taaleri.com

Taaleri Plc – Managers’ Transactions – Juhani Elomaa

Written by Customer Service on September 16, 2020. Posted in Public Companies.

TAALERI PLC MANAGERS’ TRANSACTIONS 16 SEPTEMBER 2020 AT 13.00 (EET)Person subject to the notification requirementName: Elomaa, JuhaniPosition: Member of the Board/Deputy memberIssuer: Taaleri OyjLEI: 743700LSJBDD7TMLAD92Notification type: INITIAL NOTIFICATIONReference number: 743700LSJBDD7TMLAD92_20200916092608_3____________________________________________Transaction date: 2020-09-15Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000062195Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 725 Unit price: 7 EURAggregated transactions(1): Volume: 725 Volume weighted average price: 7 EURTaaleri PlcCommunicationsSophie Jolly, Head of Communications and IR, tel. +358 40 828 7317, sophie.jolly@taaleri.com

Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, Accustem Sciences

Written by Customer Service on September 16, 2020. Posted in Public Companies.

NEW YORK and LONDON, Sept. 16, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, and focused on innovative therapeutics for oncology, inflammation and infectious disease, today announced plans for demerging its StemPrintER asset into a separate and independently listed public company, Accustem Sciences Limited.StemPrintER is a best-in-class genomic signature-based assay for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. In a side-by-side comparison study, StemPrintER was 40% more accurate than the Oncotype DX assay. In 2019, Tiziana presented two posters at the American Society for Clinical Oncology...

Retinal Disease Therapeutics Market to Rise at 8.6% CAGR and Reach USD 21,318.0 Million by 2026, Facilitated by Increasing Regulatory Approvals for Favouring Drugs, says Fortune Business Insights

Written by Customer Service on September 16, 2020. Posted in Mergers And Acquisitions.

Pune, Sept. 16, 2020 (GLOBE NEWSWIRE) — The global retinal disease therapeutics market is likely to expand at an impressive rate driven by recent government participation towards prevention and control of retinal diseases. According to a report published by Fortune Business Insights, titled “Retinal Disease Therapeutics: Global Market Analysis, Insights, and Forecast, 2019-2026,” the market is likely to reach US$ 21,318.0 Mn by the end of 2026. The market was valued at US$ 11,044.2 Mn in 2018 and is likely to witness a CAGR of 8.6% in the forecast period.Highlights of the Report:Analysis of the impact of Covid-19 that the market would face in the near future.In-depth analysis of the growth drivers and obstacles.Profile of all the companies operating in the market.Elaborate data about the dominating region.Competitive landscape consisting...

Global Distributed Antenna System Market to Reach Promising Heights on Account of Adoption of Wireless Data Adoption, says Fortune Business Insights

Written by Customer Service on September 16, 2020. Posted in Mergers And Acquisitions.

Pune, Sept. 16, 2020 (GLOBE NEWSWIRE) — The increasing mobile data traffic all around the world is creating growth opportunities for the global distributed antenna system market, finds Fortune Business Insights in their new study. The study is titled, “Distributed Antenna System Market Size, Share and Global Trend by Components (Hardware & Service), By Technology (Cellular/Commercial DAS & Public Safety DAS), By Applications (Hospitality, Education, Transportation and others) and Geography Forecast till 2025.”According to Fortune Business Insights, cellular or commercial DAS systems segment is expected to dominate the market in terms of technology. This is because such devices have multifunctional terminals that offer a range of applications making better signal receptions more relevant and that too on a single platformClick...

Atos rated a top score of triple A for the fourth consecutive year in MSCI ESG ranking

Written by Customer Service on September 16, 2020. Posted in Public Companies.

Atos ranks among the top 4% of companies in its industry in Morgan Stanley Capital International’s (MSCI) Environment Social Governance rating 2020Paris, September 16, 2020 – Atos, a global leader in digital transformation, today announced that it has received the highest score – triple A – in the ESG (Environmental, Social, governance) rating from MSCI (Morgan Stanley Capital International)1. Atos is ranked as a leader in the software and services industry out of 139 companies, which are evaluated in the MSCI ACWI Index.Atos has held a triple A score from MSCI, on a rating scale ranging from triple C to triple A, since 2017. Morgan Stanley Capital International (MSCI) is one of the leading rating agencies that analyses the ESG practices of thousands of companies around the world and aims to measure the resilience of companies...

Atos obtient la note RSE triple A par l’agence MSCI pour la quatrième année consécutive

Written by Customer Service on September 16, 2020. Posted in Public Companies.

Atos se classe parmi les 4% des entreprises leaders de son secteur dans le classement RSE de Morgan Stanley Capital International (MSCI) en 2020 Paris, le 16 septembre 2020 – Atos, leader international de la transformation digitale, vient de recevoir la note triple A, qui représente la plus haute notation, dans le classement RSE de l’agence MSCI (Morgan Stanley Capital International)1. Atos se positionne dans les 4% des entreprises leaders parmi les 139 entreprises évaluées dans l’industrie des services et logiciels de l’indice MSCI ACWI.En 2020, Atos obtient, pour la quatrième année consécutive, la note AAA par MSCI (sur une échelle de notation allant de triple C à triple A). Morgan Stanley Capital International (MSCI) est l’une des principales agences de notation qui analyse les pratiques environnementales, sociales et de gouvernance...

Month: September 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals